Evidence map›Paper›PMID 36673565›Full record

ArticleHealthcare (Basel, Switzerland)2023

Clinical Characteristics in the Acute Phase of COVID-19 That Predict Long COVID: Tachycardia, Myalgias, Severity, and Use of Antibiotics as Main Risk Factors, While Education and Blood Group B Are Protective.

Jose Guzman-Esquivel, Martha A Mendoza-Hernandez, Hannah P Guzman-Solorzano, Karla A Sarmiento-Hernandez, Iram P Rodriguez-Sanchez, Margarita L Martinez-Fierro, Brenda A Paz-Michel, Efren Murillo-Zamora, Fabian Rojas-Larios, Angel Lugo-Trampe and 3 more

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Jose Guzman-EsquivelSchool of Medicine, University of Colima, Colima 28040, Mexico.
Martha A Mendoza-HernandezSchool of Medicine, University of Colima, Colima 28040, Mexico.
Hannah P Guzman-SolorzanoSchool of Medicine, University of Colima, Colima 28040, Mexico.
Karla A Sarmiento-HernandezSchool of Medicine, University of Colima, Colima 28040, Mexico.
Iram P Rodriguez-SanchezMolecular and Structural Physiology Laboratory, School of Biological Sciences, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Mexico.ORCID 0000-0002-5988-4168
Margarita L Martinez-FierroMolecular Medicine Laboratory, Unidad de Medicina Humana y Ciencias de la Salud, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0003-1478-9068
Brenda A Paz-MichelSchool of Medicine, University of Colima, Colima 28040, Mexico.
Efren Murillo-ZamoraSchool of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0002-1118-498X
Fabian Rojas-LariosSchool of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0003-1744-9173
Angel Lugo-TrampeFaculty of Human Medicine, Campus IV, Universidad Autónoma de Chiapas, Tapachula 30580, Mexico.
Jorge E Plata-FlorenzanoCancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Marina Delgado-MachucaSchool of Medicine, University of Colima, Colima 28040, Mexico.
Ivan Delgado-EncisoSchool of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0001-9848-862X
Universidad de Colima · MXMexican Social Security Institute · MXUniversidad Autónoma de Chiapas · MXUniversidad Autónoma de Nuevo León · MXUniversidad Autónoma de Zacatecas "Francisco García Salinas" · MX

Funding

Consejo Nacional de Ciencia y Tecnología 319282
6 · The paper itself

Abstract

backgroundRisk factors for developing long COVID are not clearly established. The present study was designed to determine if any sign, symptom, or treatment of the acute phase, or personal characteristics of the patient, is associated with the development of long COVID.

methodsA cohort study was carried out, randomly selecting symptomatic COVID-19 patients and not vaccinated. The severity of the acute illness was assessed through the number of compatible COVID-19 symptoms, hospitalizations, and the symptom severity score using a 10-point visual analog scale.

resultsAfter multivariate analysis, a severity score ≥8 (RR 2.0, 95%CI 1.1-3.5,

conclusionsFurther studies in diverse populations over time are needed to expand the knowledge that could lead us to prevent and/or treat long COVID.

Indexed as

antibioticsCOVID-19long COVIDrisk factorSARS-CoV-2tachycardia

Identifiers

PMID36673565
PMCPMC9858709
OpenAlexW4313827486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.